Itsuki Anzai

564 total citations
17 papers, 321 citations indexed

About

Itsuki Anzai is a scholar working on Neurology, Infectious Diseases and Biomaterials. According to data from OpenAlex, Itsuki Anzai has authored 17 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Infectious Diseases and 3 papers in Biomaterials. Recurrent topics in Itsuki Anzai's work include SARS-CoV-2 and COVID-19 Research (6 papers), Amyotrophic Lateral Sclerosis Research (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Itsuki Anzai is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Amyotrophic Lateral Sclerosis Research (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Itsuki Anzai collaborates with scholars based in Japan. Itsuki Anzai's co-authors include Yoshiaki Furukawa, Shuji Akiyama, Yoshiharu Matsuura, Eiichi Tokuda, Rigel Suzuki, Takasuke Fukuhara, Yuzy Fauzyah, Yuhei Morioka, Shiho Torii and Chikako Ono and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Scientific Reports.

In The Last Decade

Itsuki Anzai

17 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Itsuki Anzai Japan 10 108 106 98 37 33 17 321
Puneet Juneja United States 11 54 0.5× 57 0.5× 265 2.7× 17 0.5× 5 0.2× 19 433
Mei Dang Singapore 13 55 0.5× 30 0.3× 276 2.8× 93 2.5× 25 0.8× 32 454
Weihong Gu China 8 21 0.2× 91 0.9× 104 1.1× 32 0.9× 5 0.2× 17 338
Tatsuo Matsushita United States 9 23 0.2× 58 0.5× 265 2.7× 26 0.7× 12 0.4× 27 421
Aurélie Couesnon France 8 149 1.4× 109 1.0× 123 1.3× 21 0.6× 3 0.1× 17 345
Nathalie Croteau Canada 8 87 0.8× 34 0.3× 267 2.7× 31 0.8× 5 0.2× 16 466
Alessandra Maria Vitale Italy 9 21 0.2× 26 0.2× 200 2.0× 20 0.5× 2 0.1× 21 284
Anurag Misra India 9 19 0.2× 130 1.2× 210 2.1× 39 1.1× 15 388
Aram J. Krauson United States 11 40 0.4× 89 0.8× 322 3.3× 9 0.2× 1 0.0× 14 481
Corey M. Summers United States 9 29 0.3× 17 0.2× 118 1.2× 75 2.0× 2 0.1× 12 280

Countries citing papers authored by Itsuki Anzai

Since Specialization
Citations

This map shows the geographic impact of Itsuki Anzai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itsuki Anzai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itsuki Anzai more than expected).

Fields of papers citing papers by Itsuki Anzai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itsuki Anzai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itsuki Anzai. The network helps show where Itsuki Anzai may publish in the future.

Co-authorship network of co-authors of Itsuki Anzai

This figure shows the co-authorship network connecting the top 25 collaborators of Itsuki Anzai. A scholar is included among the top collaborators of Itsuki Anzai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itsuki Anzai. Itsuki Anzai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Anzai, Itsuki, Junso Fujita, Chikako Ono, et al.. (2024). Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain. Microbiology Spectrum. 12(4). e0365523–e0365523. 2 indexed citations
2.
Anzai, Itsuki, et al.. (2024). Synthesis of Low‐Molecular‐Weight Fucoidan Analogue and Its Inhibitory Activities against Heparanase and SARS‐CoV‐2 Infection. Angewandte Chemie International Edition. 64(6). e202411760–e202411760. 3 indexed citations
3.
Hirano, Junki, Itsuki Anzai, Yuta Kanai, et al.. (2023). Electrolyzed hypochlorous acid water exhibits potent disinfectant activity against various viruses through irreversible protein aggregation. Frontiers in Microbiology. 14. 1284274–1284274. 6 indexed citations
4.
Fujita, Junso, Fumiaki Makino, Haruyasu Asahara, et al.. (2023). Epoxidized graphene grid for highly efficient high-resolution cryoEM structural analysis. Scientific Reports. 13(1). 2279–2279. 14 indexed citations
5.
Tamura, Tomokazu, Shiho Torii, Kentaro Kajiwara, et al.. (2022). Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses. PLoS Pathogens. 18(6). e1010593–e1010593. 7 indexed citations
6.
Isaka, Yoshitaka, Taku Yoshiya, Chikako Ono, et al.. (2022). Establishment and clinical application of SARS-CoV-2 catch column. Clinical and Experimental Nephrology. 27(3). 279–287. 2 indexed citations
7.
Anzai, Itsuki, Ryota Maeda, Tokiko Watanabe, et al.. (2022). Structural insights into the rational design of a nanobody that binds with high affinity to the SARS-CoV-2 spike variant. The Journal of Biochemistry. 173(2). 115–127. 1 indexed citations
8.
Minamitani, Takeharu, Kouji Kobiyama, Junso Fujita, et al.. (2022). Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein. Scientific Reports. 12(1). 20120–20120. 7 indexed citations
9.
Torii, Shiho, Chikako Ono, Rigel Suzuki, et al.. (2021). Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction. Cell Reports. 35(3). 109014–109014. 97 indexed citations
10.
Kitamura, Takashi, et al.. (2021). Synthesis of low-molecular weight fucoidan derivatives and their binding abilities to SARS-CoV-2 spike proteins. RSC Medicinal Chemistry. 12(12). 2016–2021. 18 indexed citations
11.
Fauzyah, Yuzy, Chikako Ono, Shiho Torii, et al.. (2020). Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation. Antiviral Research. 186. 104999–104999. 15 indexed citations
12.
Anzai, Itsuki, et al.. (2019). Oxidative misfolding of Cu/Zn-superoxide dismutase triggered by non-canonical intramolecular disulfide formation. Free Radical Biology and Medicine. 147. 187–199. 20 indexed citations
13.
Tokuda, Eiichi, Itsuki Anzai, Takao Nomura, et al.. (2017). Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis. Molecular Neurodegeneration. 12(1). 2–2. 20 indexed citations
14.
Anzai, Itsuki, et al.. (2016). Screening of Drugs Inhibiting In vitro Oligomerization of Cu/Zn-Superoxide Dismutase with a Mutation Causing Amyotrophic Lateral Sclerosis. Frontiers in Molecular Biosciences. 3. 40–40. 19 indexed citations
15.
Anzai, Itsuki, Eiichi Tokuda, Atsushi Mukaiyama, et al.. (2016). A misfolded dimer of Cu/Zn‐superoxide dismutase leading to pathological oligomerization in amyotrophic lateral sclerosis. Protein Science. 26(3). 484–496. 34 indexed citations
16.
Furukawa, Yoshiaki, Itsuki Anzai, Shuji Akiyama, et al.. (2015). Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis. Journal of Biological Chemistry. 291(8). 4144–4155. 39 indexed citations
17.
Anzai, Itsuki, et al.. (2014). A Primary Role for Disulfide Formation in the Productive Folding of Prokaryotic Cu,Zn-superoxide Dismutase. Journal of Biological Chemistry. 289(29). 20139–20149. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Puneet Juneja Breakdown of academic impact, for papers by Mei Dang Breakdown of academic impact, for papers by Weihong Gu Breakdown of academic impact, for papers by Tatsuo Matsushita Breakdown of academic impact, for papers by Aurélie Couesnon Breakdown of academic impact, for papers by Nathalie Croteau Breakdown of academic impact, for papers by Alessandra Maria Vitale Breakdown of academic impact, for papers by Anurag Misra Breakdown of academic impact, for papers by Aram J. Krauson Breakdown of academic impact, for papers by Corey M. Summers
Rankless by CCL
2026